Buprenorphine Buccal Film Suppliers & Bulk Manufacturers
Available Forms: Buccal film (placed inside the cheek for rapid absorption)
Available Strengths: 75 µg, 150 µg, 300 µg, and 450 µg
Reference Brands: Belbuca
Category:
Buccal Films/ Sublingual films
Buprenorphine buccal film acts by binding to opioid receptors in the brain, reducing pain perception. It provides rapid, long-lasting pain relief, supporting stable opioid levels. Benefits include improved dosing convenience, quicker onset, sustained pain control, reduced opioid misuse risk, and enhanced patient adherence in managing chronic pain.
Buprenorphine Buccal Film is available in Buccal film (placed inside the cheek for rapid absorption)
and strengths such as 75 µg, 150 µg, 300 µg, and 450 µg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Buprenorphine Buccal Film is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Buprenorphine Buccal Film can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Buprenorphine buccal film is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. In the US, FDA approval involved extensive clinical validation, safety assessments, and GMP compliance, while in the EU, CE marking certifies conformity with MDR standards. These products undergo validation, stability testing, and audits, with detailed documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective buprenorphine buccal films supporting opioid dependence treatment and chronic pain management worldwide, promoting safe, regulated opioid therapies.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing